Treatment and course of different subtypes of status epilepticus

Epilepsy Research

Volumn 107, Issue 1-2, 2013, Pages 156-162

  Rantsch, Kristin ^a   Walter, Uwe ^a   Wittstock, Matthias ^a   Benecke, Reiner ^a   Rösche, Johannes ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Clonazepam; Combination therapy; Outcome criteria; Refractory status epilepticus; Treatment delay

Indexed keywords

ANESTHETIC AGENT; CLONAZEPAM; DIAZEPAM; ETIRACETAM; HARKOSERIDE; LORAZEPAM; MIDAZOLAM; PHENYTOIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG EFFICACY; EPILEPTIC STATE; FEMALE; GENERALIZED CONVULSIVE STATUS EPILEPTICUS; HUMAN; LIMBIC COMPLEX PARTIAL STATUS EPILEPTICUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONCONVULSIVE STATUS EPILEPTICUS; NONLIMBIC COMPLEX PARTIAL STATUS EPILEPTICUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SUBTLE STATUS EPILEPTICUS;

CLONAZEPAM; COMBINATION THERAPY; OUTCOME CRITERIA; REFRACTORY STATUS EPILEPTICUS; TREATMENT DELAY;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84886945866     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2013.08.001     Document Type: Article

References (38)

1. Agarval P., Kumar N., Chandra R., Gupta G., Antony A.R., Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007, 16:527-532.
2. Alldregde B.K., Gelb A.M., Isaacs S.M., Corry M.D., Allen F., Ulrich S.K., Gottwald M.D., O'Neil N., Neuhaus J.M., Segal M.R., Lowenstein D.H. A comparison of lorazepam, diazepam and placebo for the treatment of out-of-hospital status epilepticus. N. Engl. J. Med. 2001, 345:631-637.
3. Aranda A., Foucart G., Ducassé J.L., Grolleau S., McGonigal A., Valton L. Generalized convulsive status epilepticus management in adults: a cohort study with evaluation of professional practice. Epilepsia 2010, 53:2159-2167.
4. Cook A.M., Castle A., Green A., Lesch C., Morrison C., Rhoney D., Parker D., Tesoro E., Brophy G., Goodwin H., Gokun J., Makii J., McAllen K., Bledsoe K., Sangha K., Weant K., Liang N., Murphy-Human T. Practice variations in the management of status epilepticus. Neurocrit. Care 2012, 17:24-30.
5. Gastaut H., Courjon J., Poire R., Weber M. Treatment of status epilepticus with a new benzodiazepine more active than diazepam. Epilepsia 1971, 12:197-214.
6. Herman S.T. The electroencephalogram of nonconvulsive status epilepticus. Nonconvulsive status epilepticus. 2009, 41-61. Demos Medical Publishing, New York. P.W. Kaplan, F.W. Drislane (Eds.).
7. Jaques L., Rossetti A.O. Newer antiepileptic drugs in the treatment of status epilepticus: Impact on prognosis. Epilepsy Behav. 2012, 24:70-73.
8. Kellinghaus C., Stögbauer F. Treatment of status epilepticus in a large community hospital. Epilepsy Behav. 2012, 23:235-240.
9. Kälviäinen R. Status epilepticus treatment guidelines. Epilepsia 2007, 48(Suppl. 8):99-102.
10. Kurthen, M., Janzen, R.W.C., Lerche, H., Schmidt, D., Schneider, D., Stefan, H., Steinhoff, B., Trinka, E., & Wieser, H.G. (2008). Leitlinien der DGN-Status epilepticus im Erwachsenenalter. http://www.dgn.org/inhalte-a-z/507-leitlinien-der-dgn-status-epilepticus-im-erwachsenenalter (last visit 3.07.11).
11. Leppik I.E., Derivan A.T., Homan R.W., Walker J., Ramsay R.E., Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983, 249:1452-1454.
12. Lowenstein D.H., Alldredge B.K. Current concepts: status epilepticus. N. Engl. J. Med. 1998, 338:970-976.
13. Misra U.K., Kalita J., Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 2006, 67:340-342.
14. Misra U.K., Kalita J., Maurya P.K. Levetiracetam versus lorazepam in status epilepticus: a randomized, open labeled pilot study. J. Neurol. 2012, 259:645-648.
15. Muayquil T., Rowe B.H., Ahmed S.N. Treatment adherence and outcomes in the management of convulsive status epilepticus in the emergency room. Epileptic Disord. 2007, 9:43-53.
16. Navarro V., Dagron C., Demeret S., An K., Lamhaut L., Bolgert F., Baulac M., Carli P. A prehospital randomized trial in convulsive status epilepticus. Epilepsia 2012, 52(Suppl. 8):48-49.
17. Rantsch K., Pohley I., Benecke R., Rösche J. Erfahrungen mit Lacosamid in der Behandlung des Status epilepticus. Akt Neurol. 2012, 39:425-428.
18. Rantsch K., Walter U., Wittstock M., Benecke R., Rösche J. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure 2011, 20:529-532.
19. Rösche J., Pohley I., Rantsch K., Walter U., Benecke R. Erfahrungen mit Levetiracetam in der Behandlung des Status epilepticus. Fortschr. Neurol. Psychiatrie 2013, 81:21-27.
20. Rösche J., Rantsch K., Benecke R. Pregabalin und Gabapentin als mögliche Therapieoptionen in der Behandlung des Status epilepticus. Psychopharmakotherapie 2012, 19:209-213.
21. Rösche J., Schley A., Schwesinger A., Grossmann A., Mach H., Benecke R., Walter U. Recurrent aphasic status epilepticus after prolonged generalized tonic-clonic seizures versus special feature of Todd's paralysis. Epilepsy Behav. 2011, 20:132-137.
22. Rosenow F., Hamer H.M., Knake S. The epidemiology of convulsive and nonconvulsive status epilepticus. Epilepsia 2007, 48(Suppl. 8):82-84.
23. Rossetti A.O., Alvarez V., Januel J.M., Burnand B. Treatment deviation from guidelines does not influence status epilepticus prognosis. J. Neurol. 2013, 260:412-428.
24. Rossetti A.O., Logroscino G., Milligan T.A., Michaelides C., Ruffieux C., Bromfield E.B. Status Epilepticus Severity Score (STESS) a tool to orient early treatment strategy. J. Neurol. 2008, 255:1561-1566.
25. Rossetti A.O., Milligan T.A., Vulliémoz S., Michaelides C., Bertschi M., Lee J.W. A randomized trial for the treatment of refractory status epilepticus. Neurocrit. Care 2010, 14:4-10.
26. Rossetti A.O., Novy J., Ruffieux C., Olivier P., Foletti G.B., Hayoz D., Burnand B., Logroscino G. Management and prognosis of status epilepticus according to hospital setting: a prospective study. Swiss Med. Wkly. 2009, 139:719-723.
27. Scholtes F.B., Renier W.O., Meinardi H. Generalised convulsive status epilepticus: causes, therapy and outcome in 346 patients. Epilepsia 1994, 35:1104-1112.
28. Scholtes F.B., Renier W.O., Meinardi H. Simple partial status epilepticus: causes, treatment, and outcome in 47 patients. J. Neurol. Neurosurg. Psychiatry 1996, 61:90-92.
29. Scholtes F.B., Renier W.O., Meinardi H. Non-convulsive status epilepticus: causes, treatment, and outcome in 65 patients. J. Neurol. Neurosurg. Psychiatry 1996, 61:93-95.
30. Shorvon S. What is nonconvulsive status epilepticus, and what are its subtypes?. Epilepsia 2007, 48(Suppl. 8):35-38.
31. Shorvon S., Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011, 134:2802-2818.
32. Silbergleit R., Durkalski V., Lowenstein D., Convit R., Pancioli A., Palesch Y., Barsan W. Intramuscular versus intravenous therapy for prehospital status epilepticus. N. Engl. J. Med. 2012, 366:591-600. NETT Investigators.
33. Sutter R., Kaplan P.W. Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey. Epilepsia 2012, 53(Suppl.3):1-51.
34. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., Handforth A., Faught E., Calabrese V.P., Uthman B.M., Ramsay R.E., Mamdani M.B. A comparison of four treatments for generalized convulsive status epilepticus. N. Engl. J. Med. 1998, 339:792-798.
35. Troester M.M., Hastriter E.V., Ng Y.T. Dissolving oral clonazepam wavers in the acute treatment of prolonged seizures. J. Child Neurol. 2010, 25:1468-1472.
36. Vignatelli L., Rinaldi R., Baldin E., Tinuper P., Michelucci R., Galeotti M., Carolis de P., D'Alessandro R. Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts. J. Neurol. 2008, 255:197-204.
37. WHO Collaboration Centre for Drug Statistics Methodology (2011) Oslo ATC/DDD index 2011. http://whocc.no. (last visit 14.02.11).
38. Zelano J., Kumlien E. Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: a systematic review. Seizure 2012, 21:233-236.